Cardiovascular Systems Inc.

38.33+0.1100+0.29%Vol 22.62K1Y Perf -3.30%
Apr 16th, 2021 11:00 DELAYED
BID38.23 ASK38.41
Open38.48 Previous Close38.22
Pre-Market- After-Market-
 - -%  - -
Target Price
46.57 
Analyst Rating
Moderate Buy 2.25
Potential %
21.21 
Finscreener Ranking
★★★★+     58.48
Insiders Trans % 3/6/12 mo.
-/-/27 
Value Ranking
★★★★+     58.99
Insiders Value % 3/6/12 mo.
-/-/4 
Growth Ranking
★★★     52.45
Insiders Shares Cnt. % 3/6/12 mo.
-/-/4 
Income Ranking
 —    -
Market Cap1.54B 
Earnings Rating
Strong Sell
Price Range Ratio 52W %
51.65 
Earnings Date
4th May 2021

Today's Price Range

38.2638.62

52W Range

27.7048.28

5 Year PE Ratio Range

-1 300.00912.30

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Neutral
Performance
1 Week
5.78%
1 Month
-6.71%
3 Months
-14.44%
6 Months
-0.93%
1 Year
-3.30%
3 Years
68.44%
5 Years
173.39%
10 Years
253.23%

TickerPriceChg.Chg.%
CSII38.330.11000.29
AAPL133.91-0.5900-0.44
GOOG2 292.01-4.6500-0.20
MSFT259.12-0.3800-0.15
XOM56.93-0.0500-0.09
WFC43.371.13002.68
JNJ161.080.69000.43
FB305.37-2.4500-0.80
GE13.47-0.0800-0.59
JPM153.851.68001.10
Financial StrengthValueIndustryS&P 500US Markets
5.40
6.10
0.07
0.08
-9.40
Leverage Ratio 1.20
ProfitabilityValueIndustryS&P 500US Markets
78.60
-7.90
-6.00
-13.40
-11.00
RevenueValueIndustryS&P 500US Markets
167.26M
4.16
-2.39
3.55
Earnings HistoryEstimateReportedSurprise %
Q02 2021-0.070.00100.00
Q01 2021-0.23-0.0578.26
Q04 2020-0.44-0.432.27
Q03 2020-0.09-0.0811.11
Q02 2020-0.03-0.10-233.33
Q01 2020-0.09-0.17-88.89
Q04 20190.040.040.00
Q03 2019-0.040.02150.00
Earnings Per EndEstimateRevision %Trend
3/2021 QR-0.10-66.67Negative
6/2021 QR-0.05-150.00Negative
6/2021 FY-0.200.00-
6/2022 FY-0.17-112.50Negative
Next Report Date4th May 2021
Estimated EPS Next Report-0.10
Estimates Count7
EPS Growth Next 5 Years %-
Volume Overview
Volume22.62K
Shares Outstanding40.19M
Trades Count438
Dollar Volume7.00M
Avg. Volume209.92K
Avg. Weekly Volume144.08K
Avg. Monthly Volume201.65K
Avg. Quarterly Volume208.40K

Cardiovascular Systems Inc. (NASDAQ: CSII) stock closed at 38.22 per share at the end of the most recent trading day (a 0.76% change compared to the prior day closing price) with a volume of 102.89K shares and market capitalization of 1.54B. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 779 people. Cardiovascular Systems Inc. CEO is Scott R. Ward.

The one-year performance of Cardiovascular Systems Inc. stock is -3.3%, while year-to-date (YTD) performance is -12.66%. CSII stock has a five-year performance of 173.39%. Its 52-week range is between 27.7 and 48.28, which gives CSII stock a 52-week price range ratio of 51.65%

Cardiovascular Systems Inc. currently has a PE ratio of -63.70, a price-to-book (PB) ratio of 5.34, a price-to-sale (PS) ratio of 8.83, a price to cashflow ratio of 289.80, a PEG ratio of 2.32, a ROA of -6.81%, a ROC of -8.46% and a ROE of -9.39%. The company’s profit margin is -11.00%, its EBITDA margin is -6.00%, and its revenue ttm is $167.26 Million , which makes it $4.16 revenue per share.

Of the last four earnings reports from Cardiovascular Systems Inc., there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $-0.10 for the next earnings report. Cardiovascular Systems Inc.’s next earnings report date is 04th May 2021.

The consensus rating of Wall Street analysts for Cardiovascular Systems Inc. is Moderate Buy (2.25), with a target price of $46.57, which is +21.21% compared to the current price. The earnings rating for Cardiovascular Systems Inc. stock is Strong Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Cardiovascular Systems Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Cardiovascular Systems Inc. has a Neutral technical analysis rating based on Technical Indicators (ADX : 9.47, ATR14 : 1.54, CCI20 : -12.59, Chaikin Money Flow : -0.08, MACD : -1.38, Money Flow Index : 57.68, ROC : 1.06, RSI : 53.61, STOCH (14,3) : 46.09, STOCH RSI : 1.00, UO : 45.01, Williams %R : -53.91), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Cardiovascular Systems Inc. in the last 12-months were: Alexander Rosenstein (Sold 5 377 shares of value $171 745 ), Erik Paulsen (Buy at a value of $13 140), Jeffrey S. Points (Buy at a value of $32 010), Martha Goldberg Aronson (Buy at a value of $193 310), Rhonda J. Robb (Buy at a value of $31 969), Sandra M. Sedo (Sold 3 354 shares of value $107 538 ), Scott R. Ward (Buy at a value of $32 187)

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
3 (37.50 %)
3 (50.00 %)
2 (33.33 %)
Moderate Buy
1 (12.50 %)
0 (0.00 %)
0 (0.00 %)
Hold
3 (37.50 %)
3 (50.00 %)
3 (50.00 %)
Moderate Sell
1 (12.50 %)
0 (0.00 %)
1 (16.67 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingModerate Buy
2.25
Moderate Buy
2.00
Moderate Buy
2.50

Cardiovascular Systems Inc.

Cardiovascular Systems Inc is a medical technology company focused on patients with peripheral and coronary artery diseases. Its peripheral artery disease systems are catheter-based platforms used to treat plaque in leg arteries above and below the knee. The firm's orbital atherectomy systems are used in peripheral and coronary commercial applications. Its OAS products include the Diamondback 360 Peripheral and Stealth 360 systems. Sales of Peripheral OAS contribute the majority of revenue. Cardiovascular systems generates the vast majority of its revenue in the United States.

CEO: Scott R. Ward

Telephone: +1 651 259-1600

Address: 1225 Old Highway 8 Northwest, St. Paul 55112-6416, MN, US

Number of employees: 779

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

0%100%

Bearish Bullish

50%50%

Bearish Bullish

53%47%

Bearish Bullish

56%44%

News

Stocktwits